← Leaderboards
Eleftherios P Diamandis
Mt Sinai Hosp-Samuel Lunenfeld Res Inst
$3,247,600
Attributed
$3,247,600
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $434.5K · FY2006–24$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,247,600 · 7
By mechanism
U01$1,425,461 · 1
R21$1,175,822 · 5
R01$646,317 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Early Diagnosis”
- Michael W Weiner · Northern California Institute Res &Educ$162,576,753
- Mitchell D Schnall · University Of Pennsylvania$148,421,012
- David Heimbrook · Leidos Biomedical Research, Inc.$98,656,722
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$85,695,840
- Sharon A Nachman · Johns Hopkins University$77,262,665
- Peter J O'Dwyer · University Of Pennsylvania$75,791,391
Research focus
Early DiagnosisSerumSymptomsBiomarkerDiagnosticSamplingDiagnosisAlzheimer&AposEnzyme-Linked Immunosorbent AssaySensitivity And SpecificityStagingTechnologyReceiver Operating CharacteristicsCategoriesFamilyResponseLaboratoriesBenignLiquid SubstanceBiologicalApplications GrantsBaseProteinsWoman
Grant awards (19)
Discovery and validation of biomarkers of autoimmunity in Alzheimer's Disease.$228,042
R21 · FY2024 · AG · contact PI
Discovery and validation of biomarkers of autoimmunity in Alzheimer's Disease.$138,240
R21 · FY2023 · AG · contact PI
An integrated systems biology approach for ovarian cancer biomarker discovery$89,000
U01 · FY2015 · CA · contact PI
An integrated systems biology approach for ovarian cancer biomarker discovery$257,249
U01 · FY2014 · CA · contact PI
An integrated systems biology approach for ovarian cancer biomarker discovery$248,982
U01 · FY2013 · CA · contact PI
An integrated systems biology approach for ovarian cancer biomarker discovery$264,554
U01 · FY2012 · CA · contact PI
An integrated systems biology approach for ovarian cancer biomarker discovery$264,033
U01 · FY2011 · CA · contact PI
An integrated systems biology approach for ovarian cancer biomarker discovery$301,643
U01 · FY2010 · CA · contact PI
ALCAM and BCAM: Two New Breast Cancer Biomarkers$132,840
R21 · FY2010 · CA · contact PI
ALCAM and BCAM: Two New Breast Cancer Biomarkers$110,700
R21 · FY2009 · CA · contact PI
KALLIKREINS AS DIAGNOSTIC MARKERS OF OVARIAN CARCINOMA$216,880
R01 · FY2008 · CA · contact PI
KALLIKREINS AS DIAGNOSTIC MARKERS OF OVARIAN CARCINOMA$214,733
R01 · FY2007 · CA · contact PI
KALLIKREINS AS DIAGNOSTIC MARKERS OF OVARIAN CARCINOMA$214,704
R01 · FY2006 · CA · contact PI
Human Kallikrein 4 (hK4): A New Prostatic Biomarker?$108,000
R21 · FY2003 · CA
A New Biomarker for Ovarian Cancer Detection$100,000
R21 · FY2003 · CA
Human Kallikrein 4 (hK4): A New Prostatic Biomarker?$108,000
R21 · FY2002 · CA
A New Biomarker for Ovarian Cancer Detection$100,000
R21 · FY2002 · CA
CANDIDATE NEW BIOMARKER FOR BREAST CANCER DIAGNOSIS$75,000
R21 · FY2001 · CA
CANDIDATE NEW BIOMARKER FOR BREAST CANCER DIAGNOSIS$75,000
R21 · FY2000 · CA